Experience with sirolimus (SRL)-based immunosuppression following orthotopic liver transplantation (OLT) is rapidly accumulating. In combination with calcineurin inhibitors (CNIs), SRL may reduce the incidence of acute rejection and lower overall required drug levels. This study sought to quantify l
β¦ LIBER β¦
Antibody-Based Immunosuppression Following Liver Transplantation: The Plot Thickens
β Scribed by J. K. Heimbach; M. R. Charlton
- Book ID
- 114805452
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 37 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sirolimus-based immunosuppression follow
β
Michael A. Zimmerman; James F. Trotter; Michael Wachs; Tom Bak; Jeffrey Campsen;
π
Article
π
2008
π
John Wiley and Sons
π
English
β 124 KB
Pharmacoeconomic study of tacrolimus-bas
β
J.M Rabkin; C.L Corless; H.R Rosen; A.J Olyaei
π
Article
π
2001
π
Elsevier Science
π
English
β 80 KB
cyclosporine-based quadruple induction t
β
S Jonas; O Guckelberger; A.R MΓΌller; J.M Langrehr; U Settmacher; S.G Tullius; T.
π
Article
π
2002
π
Elsevier Science
π
English
β 76 KB
Reduced acute rejection after liver tran
β
Darius F Mirza; Bridget K Gunson; Zahir Soonawall; Jacques Pirenne; A David Maye
π
Article
π
1997
π
The Lancet
π
English
β 48 KB
Characterization of the Impaired Antipne
β
A. R. Gennery; A. J. Cant; C. I. Baldwin; J. E. Calvert
π
Article
π
2001
π
Springer
π
English
β 50 KB
Sirolimus-based immunosuppression for li
β
Norman M. Kneteman; JosΓ© Oberholzer; Mohammed Al Saghier; Glenda A. Meeberg; Mau
π
Article
π
2004
π
John Wiley and Sons
π
English
β 123 KB
π 1 views
An increasing number of patients with hepatocellular carcinoma (HCC) are undergoing evaluation for listing for liver transplantation. Criteria for selection require ongoing review for suitability. A consecutive series of 40 patients with HCC within the standard Milan criteria (single tumors n = 19 <